Another rapid autopsy study was carried out on a KRAS G12C-mutated lung adenocarcinoma patient who developed rapid resistance after initial response to AMG510, with the observation of downregulated G2/M checkpoint regulators and E2F target genes, among other overlapping resistance mechanisms.74 Here, KRAS is linked to lung adenocarcinoma.